|
1
|
Alpha emitter radium-223 and survival in metastatic prostate cancer.
|
N Engl J Med
|
2013
|
13.90
|
|
2
|
A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer.
|
Br J Cancer
|
2010
|
1.87
|
|
3
|
Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer.
|
Br J Cancer
|
2007
|
1.84
|
|
4
|
Bcl-2 expression identifies patients with advanced bladder cancer treated by radiotherapy who benefit from neoadjuvant chemotherapy.
|
BJU Int
|
2000
|
1.47
|
|
5
|
STAMPEDE: Systemic Therapy for Advancing or Metastatic Prostate Cancer--a multi-arm multi-stage randomised controlled trial.
|
Clin Oncol (R Coll Radiol)
|
2008
|
1.42
|
|
6
|
Prostate cancer--what should be studied?
|
Eur J Cancer
|
1995
|
1.38
|
|
7
|
A phase I/II study of gemcitabine and fractionated cisplatin in an outpatient setting using a 21-day schedule in patients with advanced and metastatic bladder cancer.
|
Br J Cancer
|
2004
|
1.21
|
|
8
|
Chondroitin sulphate proteoglycans: key modulators of spinal cord and brain plasticity.
|
Exp Neurol
|
2011
|
1.09
|
|
9
|
Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
|
Cancer Res
|
2000
|
1.04
|
|
10
|
Hepatocellular carcinoma.
|
Ann Oncol
|
2001
|
1.03
|
|
11
|
National survey of radiotherapy fractionation practice in 2003.
|
Clin Oncol (R Coll Radiol)
|
2006
|
1.02
|
|
12
|
Proapoptotic genes BAX and CD40L are predictors of survival in transitional cell carcinoma of the bladder.
|
Br J Cancer
|
2003
|
0.90
|
|
13
|
Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma.
|
Br J Cancer
|
2013
|
0.88
|
|
14
|
Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer.
|
Br J Cancer
|
2004
|
0.86
|
|
15
|
BCL2 expression predicts survival in patients receiving synchronous chemoradiotherapy in advanced transitional cell carcinoma of the bladder.
|
Oncol Rep
|
2003
|
0.86
|
|
16
|
Long-term risk of salvage cystectomy after radiotherapy for muscle-invasive bladder cancer.
|
Eur Urol
|
2000
|
0.85
|
|
17
|
A phase I-II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer.
|
Ann Oncol
|
2001
|
0.85
|
|
18
|
A study of split-dose cisplatin-based neo-adjuvant chemotherapy in muscle-invasive bladder cancer.
|
Oncol Lett
|
2012
|
0.83
|
|
19
|
CD40 expression in prostate cancer: a potential diagnostic and therapeutic molecule.
|
Oncol Rep
|
2004
|
0.82
|
|
20
|
Prostate radiotherapy for men with metastatic disease: a new comparison in the STAMPEDE trial.
|
Clin Oncol (R Coll Radiol)
|
2013
|
0.82
|
|
21
|
A cancer research UK pharmacokinetic study of BPA-mannitol in patients with high grade glioma to optimise uptake parameters for clinical trials of BNCT.
|
Appl Radiat Isot
|
2009
|
0.82
|
|
22
|
Follow up by telephone. Phone clinic provides excellent support.
|
BMJ
|
1995
|
0.82
|
|
23
|
Combining gene and immunotherapy for prostate cancer.
|
Prostate Cancer Prostatic Dis
|
2007
|
0.81
|
|
24
|
CD40 expression in bladder cancer.
|
J Pathol
|
1999
|
0.79
|
|
25
|
Recent advances and future directions in the management of metastatic renal cell carcinoma.
|
Anticancer Agents Med Chem
|
2010
|
0.76
|
|
26
|
The effects and effectiveness of electromotive drug administration and chemohyperthermia for treating non-muscle invasive bladder cancer.
|
Ann R Coll Surg Engl
|
2014
|
0.75
|
|
27
|
Hepatic toxicity of liposomal encapsulated doxorubicin.
|
Lancet
|
1993
|
0.75
|
|
28
|
Treatment of brain tumours in children less than 3 years of age.
|
Eur J Cancer
|
1993
|
0.75
|
|
29
|
Toward a final design for the Birmingham boron neutron capture therapy neutron beam.
|
Med Phys
|
1999
|
0.75
|
|
30
|
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.
|
Ann Oncol
|
2016
|
0.75
|
|
31
|
Kaposi's sarcoma and AIDS.
|
Int J STD AIDS
|
1991
|
0.75
|